Strategic Management and Sustainability Assessment of AstraZeneca

This report provides a comprehensive strategic assessment of AstraZeneca, a leading pharmaceutical company. It begins with an introduction to strategic assessment and sustainability factors within the pharmaceutical industry, emphasizing AstraZeneca's global presence and innovative approach. The main body of the report delves into various strategic models, including SWOT, PESTLE, and Porter's Five Forces analyses, to evaluate AstraZeneca's internal and external environments. The SWOT analysis examines the company's strengths, weaknesses, opportunities, and threats, while the PESTLE analysis explores political, economic, social, technological, legal, and environmental factors. Porter's Five Forces analysis assesses the competitive landscape, including the bargaining power of suppliers and customers, the threat of new entrants and substitutes, and competitive rivalry. The report also examines the industry life cycle, highlighting AstraZeneca's position and strategies within the introduction, growth, maturity, and decline stages. The conclusion summarizes the key findings and offers insights into AstraZeneca's strategic direction. The report highlights AstraZeneca's innovative strategies and sustainability efforts within the pharmaceutical industry.

Strategic Management and
Sustainability Assessment 1

TABLE OF CONTENT
INRTODUCTION......................................................................................................................4
MAIN BODY.............................................................................................................................4
CONCLUSION........................................................................................................................10
REFERENCES.........................................................................................................................12

INRTODUCTION
Strategic assessment and sustainability factors can be understood as most essential
working scenarios within business parameters where varied scale competent growth space is
there for companies to further evolve on. Globally pharmaceutical industry is vividly
growing under transformation, where healthcare standards and productive services are widely
growing towards larger horizons. Astra Zeneca is one of the biggest pharmaceutical
companies having wide range of drugs, medical and healthcare services having operations
around globe. The brand has been functionally growing with best benchmarks parameters,
latest working efficacy domains and for up scaling latest healthcare facilities around globe.
Report will be conducting detailed discussion on various strategic models based on internal
and external model analysis, for further functional growth factors which bring dynamic
impact further. The study will further put research based on latest working resources, new
innovations coming within latest Coved – 19 situations for combating profound rise towards
productive functional innovations.
MAIN BODY
The global pharmaceutical industry is widely growing with vast number of
discoveries, developments and production within market drugs for use as medications to be
administered among patients to aim for curing. Pharmaceutical companies deal with generic
or brand medications within devices, where industry globally is expanding to become of the
biggest competitively growing industry for bringing on varied scale innovations. AstraZeneca
PLC is British Swedish Multinational pharmaceutical and Biotechnology Company with
headquarters at Cambridge Biomedical Campus in Cambridge, England where it has a
portfolio of products and services. The company was founded in 1999, through merger of
Swedish Astra AB and British Zeneca Group where brand has been excelling towards
advanced quality standards operatively within global horizons. Strategic analysis with usage
of various models will enable us to ideally get in detail focus on varied business operations,
latest fundamental strategies and ideologies shaping competent arenas of company. The
pharmaceutical company works with aim to cure patients with various diseases, alleviate
symptoms and deal in generic brand medications and devices informatively (Giampieri and
et.al., 2020).

SWOT model
Internal business environmental factors plays strong essential role for competitive rise
development and new innovative business planning, towards competent scale business
growth factors. Astra Zeneca swot model analysis will in detail further focus towards present
business positioning and idealistic growth factors competently advancing towards new factors
(Top 5 Strategic Planning Moves to Best Position Your Business for Success in 2020, 2019)
 Strengths: Astra Zeneca is ranked first in innovation index within pharmaceutical
services and products within medicines, where high percentage of research and
development expenditure is done. Also the quality has been profoundly shaping
competent financial revenue standards and customer brand goodwill profoundly. The
company has strong financial structure with high capital, large scale of products and
services functionally advancing among productive domains.
 Weaknesses: The company faces weakness due to lack of good leadership within
structure at top management, where brand faces wide scale operational and business
downfall due to lack of competencies within present leadership. High scale of
competition also leads to strategic expansion risk factor within varied scale resources
and larger competitive business positioning profoundly (Gauthier, 2017).
 Opportunities: Vast growth rate of opportunities are there for company to expand
towards new scale growth towards varied technology paradigms, new profound
imperative goals and to yield wide dynamic positions. There is also opportunity for
varied scale functional rise towards new pharmaceutical inventions, which comes
with leveraged specific business surge rise for larger vision oriented growth. Threats: High drug development cost, acquisitions by financially stronger and bigger
firms within wealthier companies also comes as threat for brand within new future
operations. Astra Zeneca also further faces internal and external business factors risk
where varied products, services are keenly evolving towards wider developed pace
networking.
The swot business environment further brings on varied scope for larger strength oriented
domains, which further expand towards bringing best competent innovation and vision
oriented growth towards scaled up efficacy parameters (Ho, 2016).
Pestle analysis

The pestle analysis will enable in depth focus towards macro business environment
factors, where large r focus within varied scale competitive market avenues will enable new
rise towards functional arenas. Astra Zeneca pestle analysis will enable in depth focus
towards macro business environment factors where there is varied scope for competent
innovation impacting varied surging pace, and to identify new opportunities. Pestle analysis
will further focus towards external business domains, growth towards new scale focus
horizons and also determine new fundamental business targets.
Political factors: There is uncertainty due to Brexit; increased economic and political
fluctuations come in as challenge facto where Astra Zeneca faces risk from varied range of
political factors imperatively. The political instability also comes in as one of the crucial
aspect for larger functional expansion towards business competencies profoundly, towards
which vision oriented scope is needed (Dalirazar and Sabzi, 2020).
 Economical: The Company has been affected due to decline in buying power of
possible clients and province form internal and external economic systems within
short and long run. The economic growing fluctuation also comes as an impactful
aspect, where interest rates and inflation in commercial business aspects are also
growing. Degree of rising prices within drugs also comes in as an essential parameter
which has been analysed as one of the main factor, where company is facing
challenge. Social factors: The varied aspects within demographic alterations, where tendencies
in social productive horizons bring on cultural growth facets, where macro business
factors have strong impact. The population growing demands in Covid, has been one
of the most crucial factors where internal and external social structure brings in varied
scope effectively. Social factors also come in as productive expansion opportunity,
where there is scope for ideal investments for enhanced business positioning
competitively as per innovative business surge.
 Technological factors: Artificial intelligence and innovation within manufacturing of
drugs is one of the most competent factors which have lead to strong work growth
impact within business development. There is varied opportunity to further invest in
building best technologies and investments towards resource planning among medical
science, pharmacy investments among drugs. Covid-19 vaccine invention is also one
of the major aspects where technology factors form eternal business domains has been

competently shaping, also latest health standards further bring on wider scope (Cong,
Pang and Peng, 2020). Legal factors: Decline in drug approval from regulatory bodies, changes made in
corporate tax rate in USA and impact of GDPR on operations and development of
drugs are some of the most essential legal factors. Also, pharmaceutical industry
comes with various legal obligations and specific functional innovation planning
towards new range of competencies where there is scope for larger growth domains
profoundly. Legal factors come in as one of the main aspect, where investments must
be done as per strategic scale competitive business targets and for further competent
productive expansion profoundly.
 Environmental factors: The leaders within Astra Zeneca to tackle global climate
change have varied competent scope, for scaling up larger technical growth towards
varied CSR factors. Further, environmental factors also call in for varied scale
investments towards productive sustainable costs inventions where new innovative
business planning has to be done. This also further comes in as one of the most
essential aspect within macro business world, where keen positioning and vision
oriented determinants comes in as one of the essential arena.
Porter five force analysis
Astra Zeneca is one of the leading firms within healthcare, whose premium quality
standards and productive functional expansion within business services in pharmaceutical has
evolved in recent years with best standards. Porter five force analyses is one of the best
innovative strategic management tool, used for analyzing industry and understanding of
various levers within profitability domains. It will enable us to identify impact of five
competitive forces, for bringing best profitability standards and for leveraging best scale
working innovation (Bhattacharyya and Verma, 2019).
 Bargaining power of suppliers: The bargaining powers of suppliers are based on
functional scope for keeping up competent scope for leveraging new scale
efficiency within supply chain factors. Major innovations coming in supply chain
structure brings on varied scope for larger overall growth towards new productive
determinants. The overall impact of profitability within drugs manufacturing
supply chain structure comes in as functional scope, where consistent focuses
towards varied efficacy domains are there. Astra Zeneca has own supply chain

factor, where suppliers of company are independent and also varied scale
competent focus has been given to varied efficacy parameters towards enlarged
domains.
 Bargaining power of customers: The bargaining power of customers is less due
to wide scale business capital range structure, and larger competent functional
scope among varied range of operations. Customer’s goodwill is also one of the
most essential factors, where they are willing to pay prices with best quality
strength factors actively. Also the brand has been excelling towards best
functional domains as per bargaining power of supplier, which also enables to
competently bring on dynamic growth towards varied scope. With independent
supplier’s chain, the bargaining powers of suppliers are limited to bring on any
long term impact on business structured horizons. This further connects to varied
scale work growth benchmarks, within customer’s timely supply of drugs and also
bringing best functional innovation rapidly.
 Threat of new entrants: With growing commercialisation and varied scale
innovations coming in pharmaceutical industry there are various new companies
bringing larger varied products. This factor explains that threat of new entrants
has medium force impact on business operations, where new players in
pharmaceutical industry have given rise to competition factor (Shadman and et.l
2021). As per quality factor, it can be understood that Astra Zeneca offers
premium products and drugs with best quality structures where it is hard for new
companies to compete.
 Competitive rivalry: Competitors in the pharmaceutical industry where Astra
Zeneca PLC operates are very less where it has been serving best competitive
quality benchmarks profoundly. This has been identified as main aspect where
rivalry among existing firms has medium force, where Astra Zeneca has been
aiming to serve best premium quality standards with wide scale competent surging
pace. Capturing market with varied scale best drugs and medicines has enabled
brand to imperatively expand towards strategic investments, larger scale brand
value development profoundly.
 Threat of substitutes: There are very less substitutes available for products and
drugs services, as per varied competitive production standards in Pharmaceutical
industry where Astra Zeneca operates. The strong customer brand goodwill due to
large quality standards products is one of the key strength where it has been

profoundly heading to be one of the best companies. Threat of substitutes further
enable us to explain varied keen paradigms towards keen positioning aspects,
enlarged functional expansion towards business growth factors (Katsaros,
Tsirikas. and Kosta, 2020).
Industry life cycle
The industry life cycle refers to evolution of an industry or businesses through four
stages based on business characteristics commonly worked on within each phases. Four
phases of an industry life cycle are the introduction, growth, maturity and decline stages
which further connect towards diverse paradigms for larger leveraged efficacy goals
profoundly. Astra Zeneca is one of the best premium pharmaceutical companies whose
productive functional aspects have been competently shaping innovation, larger creative
standards actively.
 Introduction: The first stage of industry life cycle explains introduction towards
market parameters with high effective marketing and innovation factors, where
specific scale diversity pertained towards promotion is huge. The Astra Zeneca at
first stage has been competently growing with varied scale functional aspects for
reaching varied customer target market, where creative innovation towards
marketing has been also growing. Distribution channels has been also specifically
growing on for varied high scale competent domains, where large investments in
marketing to establish consumer awareness within industry (Simões, 2020).
 Growth: Innovation process stage within growth, is heading for various ways to
make existing products commercially high standards and also better
manufacturing procedures which enhances delivery methods profoundly. At this
stage, Astra Zeneca has been integrating best growth targets within drugs usage
for healthcare products and competent best medical services within medicines.
Towards growth factors brand also invests in research towards Covid-19 vaccine,
where functional scope towards attaining best growth benchmarks has been
professionally worked on. Also there are varied trained sales rate increases
worked on for strong brand value growth commercially, where pharmaceutical
standards are widely expanded. Innovation has been competently growing for
existing products and services, where healthcare and medical services are largely
active.

 Shakeout: At the third stage of shakeout, company faces external factors among
business within competent products and services for gaining more market share
fundamentally towards gaining larger scope. Investments at Astra Zeneca are
widely strong productively worked on within marketing, new customer support,
product quality aspects and after sales growth which further brand value to
expand. The growth factors within pharmaceutical products are worked on, by
using best models and strategies for bringing best varied targets as per larger new
preferences (The pharma industry trends from 2020 that form our marketing
predictions for 2021, 2021). At shakeout stage, there is larger scope also for
company to further bring on competitive benchmarks.
 Maturity: The maturity stage further heads on larger strategic focus towards
enhancing consumer awareness factors, which marketing and promotions are
specifically worked on by Astra Zeneca. Furthermore, it can be analysed that
pharmaceutical industry is widely grown towards monopolistic competition where
there are new companies also coming on within varied demanding parameters.
Further Astra Zeneca has been identified as one of the best company known for
varied scale functional growth rapidly built on products globally. This is the most
important stage where company services are globally known towards competent
scale growth arenas, for best paradigms towards global standards.
 Decline: The last stage is based on decline where company may face decline due
to various internal and external business factors where functional innovation
comes in as one of the most essential factor. Furthermore, it can be analysed that
rules and regulations varying within global parameters, where rules and
regulations changes along with issues with supply of raw materials impact on
business operations. There are supply of raw materials rise and cost factor, where
new scale growth synergies has scope for larger productive avenues towards
bringing best creative expansion.
The above stages of industry life cycle have analysed in detail varied horizons and
practical working aspects within functional scenario, as per latest functional work growth
targets. Astra Zeneca has been competently growing for varied scale expansion towards
medical and healthcare products, services where best quality are being served effectively
within longer time frame. Pharmaceutical industry has optimistically been expanding with

new inventions coming towards Covid -19 medicines and vaccines, which also determine
varied innovations coming on.
CONCLUSION
From the above analysed aspects done in report, it can be concluded that Astra Zeneca
is one of the most repudiated company name within pharmaceutical company, known for
varied scale products and services within healthcare. The study has concluded research based
on various models such as swot, pestle analysis, porter five force analysis and industry life
cycle stage where there Astra Zeneca has been competently growing imperatively. Further, it
can be concluded that company established new edged profound growth towards it recent
covid-19 vaccine inventions and larger scale competent functional expansion. It can be also
concluded further, that brand has been excelling towards varied determinants for competent
functional work services profoundly, on which external factors comes in as challenge.

REFERENCES
Books and journals
Bhattacharyya, S. S. and Verma, S., 2019. The intellectual core and structure of international
business strategies (IBS). Review of International Business and Strategy.
Cong, J., Pang, T. and Peng, H., 2020. Optimal Strategies for Green Supply Chains with
Competition between Green and Traditional Suppliers. Available at SSRN 3743429.
Dalirazar, S. and Sabzi, Z., 2020. Strategic analysis of barriers and solutions to development
of sustainable buildings using PESTLE technique. International Journal of
Construction Management, pp.1-30.
Gauthier, J., 2017. Sustainable business strategies: typologies and future directions. Society
and Business Review.
Giampieri, A. and et.al., 2020. A review of the current automotive manufacturing practice
from an energy perspective. Applied Energy. 261. p.114074.
Ho, P. H., 2016. Analysis of competitive environments, business strategies, and performance
in Hong Kong’s construction industry. Journal of Management in Engineering.
32(2). p.04015044.
Katsaros, K.K., Tsirikas, A.N. and Kosta, G.C., 2020. The impact of leadership on firm
financial performance: the mediating role of employees' readiness to
change. Leadership & Organization Development Journal.
Shadman, S., and et.l 2021. The role of current and future renewable energy policies in
fortifying Malaysia’s energy security: PESTLE and SWOT analysis through
stakeholder engagement. Progress in Energy and Environment. 16. pp.1-17.
Simões, E. N., 2020. A decision support system application module-for PESTLE analysis-
competitive intelligence algorithm (Doctoral dissertation).
Online
The pharma industry trends from 2020 that form our marketing predictions for 2021. 2021.
[Online]. Available Through :<
https://www.orientation.agency/insights/pharma-marketing-trends-from-2020-
to-2021
Top 5 Strategic Planning Moves to Best Position Your Business for Success in 2020. 2019.
[Online]. Available Through : <
https://www.myasbn.com/small-business/management/top-5-strategic-planning-
moves-to-best-position-your-business-for-success-in-2020/>